報價延遲最少15分鐘:2025/07/21 10:06 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
11.92 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.30/-0.64
|
|
企業價值
1.57B
|
| 資產負債 |
|
每股賬面淨值
5.74
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
610.79M
|
|
每股收益
4.80
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/21 10:06 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China). |
